View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Analysis
March 4, 2022

Revealed: Top and emerging locations for M&A deals in the medical devices industry

The data shows that M&A activity is strongest in the US, which saw a total of 25 deals announced in the most recent quarter (2021 Q4).

By Data Journalism Team

New figures released by GlobalData have shed light on the top locations for mergers and acquisitions in the medical devices industry.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The data shows that M&A activity is strongest in the US, which saw a total of 25 deals announced in the most recent quarter (2021 Q4). That’s up from 22 deals announced in the previous quarter (2021 Q3).

China also performed well over the most recent quarter, with eight deals (down from 13 in 2021 Q3).

Which countries are emerging as M&A powerhouses?

Recent months have also seen an uptick in M&A deals in Canada. The country has seen eight deals announced over the last two complete quarters, up from an average of two deals every six months between 2019 and 2021.

That's the largest increase in M&A dealmaking in the medical devices industry for any country.

Despite being the global hotspot for M&A dealmaking in the medical devices industry, the US has had a difficult few months, with just 29 deals announced in the last two complete quarters.

That's a decrease compared the country's average of 59 deals announced every six months between 2019 and 2021, and the sharpest decrease in M&A dealmaking in the medical devices industry experienced by any country in recent months.

Globally, the situation is looking mixed for mergers and acquisitions in the medical devices industry.

A total of 68 deals were announced over the last quarter, down from 70 deals in the previous quarter but up from from an average of 59 deals per quarter over the previous three years.

GlobalData's deals database

GlobalData tracks the performance and activities of more than 675,000 companies in over 200 countries around the world.

The data analytics firm's deals database includes the details of approximately one million deals, ranging from mergers and acquisition to venture capital financing, equity offerings and debt offerings.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network